-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Since the outbreak of the new crown epidemic, human beings' understanding of the virus has been constantly refreshed.
The receptor ACE2 of the new coronavirus is a receptor protein widely distributed in the human body, mainly in organs and tissues such as the respiratory tract, intestine, kidney, heart and testis
Many studies have pointed out that the new coronavirus infection will not only bring disease and death, but also cause other complications, and cause sequelae of varying degrees and symptoms after the patient recovers
New coronavirus infection not only brings disease and death, but also causes other complications and causes sequelae of varying degrees and symptoms after the patient recovers
Dec.
On June 23, 2021, a research paper titled: Long COVID in a prospective cohort of home-isolated patients was published in Nature Medicine, a top international medical journal .
A survey of 312 patients with new coronary pneumonia in Norway on June 23, 2021 found that more than half of home-isolated young adults (16-30 years old) with mild symptoms developed long-term persistent breathing difficulties 6 months after initial infection.
On August 28, 2021, the top international medical journal "The Lancet" published a research paper entitled: 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
On August 28, 2021, the vast majority of patients with new coronary pneumonia discharged from hospital still have at least one abnormal symptom such as fatigue and muscle weakness, sleep disturbance, hair loss, loss of smell, palpitations, and joint pain 1 year after the onset
These studies have reminded us that after being infected with the new coronavirus, even after recovery, there may still be long-term sequelae, so some people call it "Long COVID"
On February 7, 2022, researchers from Washington University in St.
On February 7, 2022, researchers from Washington University in St.
What's more, even those under the age of 65 who do not have cardiovascular disease risk factors such as obesity, smoking, diabetes, etc.
The study showed that 30 days after infection with COVID-19, patients had a significantly increased risk of developing cardiovascular disease, including cerebrovascular disease, arrhythmias, ischemic and non-ischemic heart disease, pericarditis, myocarditis, heart failure and Thromboembolic disease
Patients were at significantly increased risk of cardiovascular disease, including cerebrovascular disease, arrhythmias, ischemic and non-ischemic heart disease, pericarditis, myocarditis, heart failure, and thromboembolic disease 30 days after infection with COVID-19
Overall, this comparative study showed that people who recovered from SARS-CoV-2 had a substantially increased risk of developing cardiovascular disease, including heart attack and stroke, within a year
Original source:
Original source:Xie, Y.
, Xu, E.
, Bowe, B.
et al.
Long-term cardiovascular outcomes of COVID-19 .
Nat Med (2022).
https://doi.
org/10.
1038/s41591-022-01689-3 .
leave a comment here
